TargEDys Develops New Microbiome-based Solutions for Appetite Regulation and Announces a €5.8M International Round of Financing to Demonstrate Product Clinical Efficacy

ROUEN, France, April 14, 2016 /PRNewswire/ -- This investment transaction, led jointly by Seventure Partners, NCI and Pontifax, will allow TargEDys to launch human clinical studies, with its products targeting high appetite leading to overweight, and low appetite leading to...

For more information, please visit
http://www.prnewswire.com/news-releases/[...]inical-efficacy-575703091.html

You need to login to post comments.

Feed last updated 2025/06/30 @12:06 AM

0 COMMENTS:

📊 Most Viewed News

• The complete guide to making your product international - The Nex... (15,536)
• Colaboração 2.0: Breaking Down the Language Barrier - Business ... (12,030)
• A Start-Up Bets on Human Translators Over Machines - New York Tim... (11,530)
• Immigrants 'should learn English' - Politics.co.uk (11,199)
• How OpenStack gets translated - opensource.com (11,037)
• easyJet Chooses TransPerfect for Pan-European Translation - Busin... (10,933)
• Para-Plus Translations Honored by Philadelphia Business Journal .... (10,367)
• Google Adds Customized Translations for Website Owners - PC Magaz... (10,257)

F.A.Q. | Terms and conditions